Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia.

被引:5
|
作者
Smith, Catherine Choy
Levis, Mark J.
Litzow, Mark Robert
Perl, Alexander E.
Altman, Jessica K.
Gill, Stan
Yuen, Geoffrey
Bonate, Peter
Kadokura, Takeshi
James, Angela Joubert
Liu, Charles
Nagase, Itsuro
Fisniku, Ogert
Bahceci, Erkut
机构
[1] UC San Francisco, San Francisco, CA USA
[2] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[3] Mayo Clin, Rochester, MN USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Northwestern Univ, Chicago, IL 60611 USA
[6] Astellas Pharma US Inc, Northbrook, IL USA
[7] Astellas Res Inst Amer, Skokie, IL USA
关键词
D O I
10.1200/JCO.2016.34.15_suppl.7026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7026
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Population pharmacokinetics and pharmacokinetics/pharmacodynamics of bendamustine in pediatric patients with relapsed/refractory acute leukemia
    Darwish, Mona
    Megason, Gail
    Bond, Mary
    Hellriegel, Edward
    Robertson, Philmore, Jr.
    Grasela, Thaddeus
    Phillips, Luann
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (11) : 2305 - 2315
  • [2] Burden of relapsed/refractory (RR) acute myeloid leukemia.
    Panjabi, Sumeet
    Hines, Dionne M.
    McGuiness, Catherine Balderston
    Yucel, Emre
    Yea, Steven
    McIver, Zachariah
    Wade, Rolin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Gilteritinib Monotherapy in Relapsed or Refractory Acute Myeloid Leukemia Flt3+in Adult Patients
    Bondarenko, Sergey
    Morozova, Elena
    Smirnova, Anna
    Vlasova, Yuliya
    Ayubova, Bella
    Karyagina, Elena
    Ilyasov, Ridvan
    Zorina, Natalia
    Belyaeva, Svetlana
    Tsvetkov, Nikolai
    Oleynikova, Yulia
    Barkhatov, Ildar
    Gindina, Tatiana
    Moiseev, Ivan
    Kulagin, Alexander
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 188 - 188
  • [4] Gilteritinib for the treatment of patients with FLT3 mutated relapsed or refractory acute myeloid leukemia
    Wang, Eunice S.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (03): : 105 - 112
  • [5] Clinical pharmacokinetics and pharmacodynamics of ivosidenib in Chinese patients with relapsed or refractory IDH1-mutated acute myeloid leukemia
    Yue, Zenglian
    Pan, Chaohsuan
    Wang, Siyuan
    Tse, Archie N.
    Sheng, Yucheng
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (01) : 105 - 113
  • [6] Clinical pharmacokinetics and pharmacodynamics of ivosidenib in Chinese patients with relapsed or refractory IDH1-mutated acute myeloid leukemia
    Zenglian Yue
    Chaohsuan Pan
    Siyuan Wang
    Archie N. Tse
    Yucheng Sheng
    European Journal of Clinical Pharmacology, 2024, 80 : 105 - 113
  • [7] Phase 1B/2A safety, pharmacokinetics, and pharmacodynamics study of fosciclopirox alone and in combination with cytarabine in patients with relapsed/refractory acute myeloid leukemia.
    Lin, Tara L.
    Wood, Robyn
    Ham, Tammy
    Sullivan, Taegen
    Bhattacharyya, Sangita
    Dandawate, Prasad
    Anant, Shrikant
    Santaguida, Marianne T.
    Zhang, Na
    Toren, Paul
    Jensen, Roy A.
    Taylor, John A.
    Baltezor, Michael Jay
    Dalton, Michael
    McBride, John
    Umbreit, Jay Nicholas
    McCulloch, William
    Vanderlaag, Kathryn
    Wagner, Joseph
    Weir, Scott James
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Iadademstat in combination with gilteritinib for patients with mutated FLT3 relapsed/refractory acute myeloid leukemia
    Fathi, Amir Tahmasb
    Arevalo, Mabel
    Gutierrez, Sonia
    Molero, Antonieta
    Sacilotto, Natalia
    Limon, Ana E.
    Faller, Douglas V.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Gilteritinib in the treatment of relapsed and refractory acute myeloid leukemia with a FLT3 mutation
    Chew, Serena
    Mackey, Melissa C.
    Jabbour, Elias
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [10] Gilteritinib or venetoclax in relapsed or refractory FLT3mut acute myeloid leukemia
    Murray, Graeme
    Bouligny, Ian Michael
    Patel, Tilak
    Doyel, Michael
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Ho, Thuy
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)